Our Curious Amalgam

Toggle navigation
  • About
  • Hosts
  • Gallery
  • Episodes
  • ABA
  • Search

Tag: drug prices

Casey Mulligan, Professor of Economics, University of Chicago

#241 Are PBMs Good For Competition? A Cost-Benefit Analysis of the Effects of Regulating Pharmacy Benefit Managers

Posted 2 months ago Tagged drug prices health care PBMs pharmacy benefit managers

Pharmacy benefit managers (PBMs) are being called out for engaging in allegedly anticompetitive business practices […]

https://ourcuriousamalgam.com/episode-player/2820/241-pharmacy-benefit-managers.mp3?stats-code=ocaPodcastSite
Dr. Erin Trish, Co-Director, Schaeffer Center for Health Policy & Economics, University of Southern California

#212 A Sickness or a Cure for High Drug Prices? Why PBMs Are Under the Antitrust Microscope

Posted 9 months ago Tagged drug prices FTC insulin PBMs pharmacies pharmacy benefit managers

Drug prices are top of mind for numerous patients, legislators, policy experts, and antitrust enforcers […]

https://ourcuriousamalgam.com/episode-player/2622/212-high-drug-prices-pbm.mp3?stats-code=ocaPodcastSite
Subscribe
Subscribe on iTunes
Listen on Spotify
Listen on Google Podcasts
Listen to Stitcher
Amazon music
Browse by category
Scroll to the top

Don't miss new episodes every Monday. Subscribe now!

Our Curious Amalgam explores topics in antitrust, competition, consumer protection, data protection, and privacy law around the world with leading experts in those areas. It is an amalgam because it is a group of diverse topics all in one place. It is curious because it gets the experts and asks them in-depth questions.

© 2019-2023 American Bar Association. All Rights Reserved.

NEWS AND EVENTS
What's Going on at the Antitrust Law Section

CONTACT US
podcast@ourcuriousamalgam.com

Find us on social!

Facebook Twitter Instagram LinkedIn RSS Feed

Subscribe
Subscribe on iTunes
Listen on Spotify
Listen on Google Podcasts
Listen to Stitcher
Amazon music
The opinions expressed by the participants in the podcasts are their own and do not necessarily represent those of their employers or other affiliated organizations.